Context

Vivalto Santé acquired Mathilde Médical Développement, adding four establishments — two clinics and two radiotherapy centres — to its existing Normandie footprint. The acquisition complements Vivalto Santé's existing presence in the region through the Clinique de l'Europe in Rouen and the Hôpital Pasteur in Evreux. The deal follows a series of acquisitions completed in 2019, including the Hôpital Privé du Confluent in Nantes, the Polyclinique de l'Europe in Saint-Nazaire, and the Polyclinique du Parc in Cholet, reflecting Vivalto Santé's ongoing buy-and-build strategy across the French private hospital market.

Target

Mathilde Médical Développement is a French private healthcare group based in Normandie, operating four establishments comprising two private clinics and two radiotherapy centres. The group generated annual revenues of €55 million at the time of the transaction. Its geographic positioning in Normandie makes it a highly complementary bolt-on for Vivalto Santé, which already operated the Clinique de l'Europe in Rouen and the Hôpital Pasteur in Evreux in the same region, enabling meaningful network densification and care pathway integration across the territory.